Skip to main content
MedAvail Logo MedAvail Logo
  • Overview
    • News
    • Events & Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
Site Search
  • Overview
    • News
    • Events & Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts

News

  • Overview
    • News
    • Events & Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
Normal
Press release year list 2022 2021 2020
05/12/2022
MedAvail Reports First Quarter 2022 Financial Results
04/28/2022
MedAvail to Report 2022 First Quarter Financial Results on May 12, 2022
04/08/2022
MedAvail Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
04/04/2022
MedAvail Announces Closing of Private Placement
03/31/2022
MedAvail Announces Pricing of $50 Million Private Placement
03/24/2022
MedAvail Reports Fourth Quarter and Full Year 2021 Financial Results
03/10/2022
MedAvail to Report 2021 Fourth Quarter and Full Year Financial Results on March 24, 2022
02/22/2022
MedAvail Strengthens Leadership Team
01/11/2022
MedAvail Announces Changes to Executive Management and Board of Directors; Preliminary Fourth Quarter and FY 2021 Results
01/05/2022
IMA Medical Group Significantly Expands Partnership With MedAvail, Providing Integrated SpotRx Pharmacy Experience
MedAvail Logo

Follow us:

  • follow us on facebook
  • follow us on twitter
  • follow us on linkedin
  • follow us on youtube

IR contact:

Caroline Paul

ir@medavail.com

Email alerts:

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At MedAvail, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to MedAvail to send you the requested Investor Email Alert updates.

* Required

*
*





Unsubscribe

Email alert sign up confirmation

  • Regulatory Compliance
  • Privacy Policy
  • Patent and Trademark Notice
  • Accessibility
© MedAvail Holdings Inc. All rights reserved
Powered By Q4 Inc. 5.71.0.1 (opens in new window)